- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and HealthcareBusiness Overview: IBL has multiple business units managed by an independent team of field experts. It operates in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure
IBL Indrayani Biotech has announced the publication of its audited financial results for the quarter and year ended March 31, 2026. The company's Board of Directors approved these results at a meeting. This update provides shareholders with a transparent overview of IBL's recent financial performance. Investors can access the detailed...
IBL Indrayani Biotech's Board has approved the audited financial results for the quarter and year ended March 31. For the year, consolidated revenue stood at **₹137.83 Cr**, with a profit of **₹2.16 Cr**. Standalone revenue was **₹21.90 Cr**, reporting a profit of **₹0.70 Cr**. Auditors issued a qualified opinion on...
IBL Indrayani Biotech's Board approved Q4 & FY26 audited financial results. Auditors issued a Qualified Opinion due to unconfirmed balances (loans, trade receivables) & subsidiaries not complying with IND AS. This signals significant financial reporting concerns for investors.
Indrayani Biotech has announced that the Goods and Services Tax (GST) Department has revoked the cancellation of its GST registration. The company's registration was previously cancelled due to non-filing of returns. This revocation is effective from the date the registration was originally cancelled, ensuring continuous validity for business operations. Indrayani...